Sunday, May 16, 2021

NAFDAC approves Pfizer COVID-19 Vaccine

Categories

Share

The National Agency for Food and Drug Administration and Control (NAFDAC) has approved the use of Pfizer COVID-19 vaccine in Nigeria.

NAFDAC’s approval is coming a few months after it gave a nod for the use of the Oxford-Astrazeneca jabs.

The Director-General of the Agency, Mojisola Adeyeye announced this during a virtual meeting on Friday in Abuja, explaining that the vaccine is for emergency use.

Earlier in March, Nigeria had received 3.9 million doses of the Astranezeneca jabs and flagged off the vaccination exercise during an event organized by the National Primary Health Care Development Agency (NPHCDA) in Abuja.